PCRB vs VXUS

Quick Verdict

VXUS has a lower expense ratio. VXUS delivered stronger 1-year returns. VXUS offers more diversification with 7860 holdings.

Lower Fees: VXUSHigher Returns: VXUSMore Diversified: VXUS

Side-by-Side Comparison

MetricPCRBVXUSWinner
Expense Ratio0.36%0.05%
AUM$7M$156.5B
Dividend Yield9.74%2.60%
Holdings5688,747
YTD Return-0.43%+11.13%
1Y Return+4.33%+27.13%
3Y Return (annualized)+4.09%+17.24%
5Y Return (annualized)-+8.71%
Volatility (annualized)5.6%15.1%
Max Drawdown-7.2%-39.9%
Fund FamilyFranklin Templeton Investments (US)Vanguard (US)
CategoryFixed IncomeEquity
InceptionJan 19, 2023Jan 26, 2011

PCRB vs VXUS Performance

Putnam ESG Core Bond ETF (PCRB) is a ETF from Franklin Templeton Investments (US) and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year PCRB returned +4.33% while VXUS returned +27.13%. Year to date, PCRB is down 0.43% versus a gain of 11.13% for VXUS.

Over three years, PCRB compounded at +4.09% per year against +17.24% for VXUS. Across the full 3-year window we track, VXUS has the edge at +4.66% annualized vs +3.23%. Past performance does not guarantee future results.

Risk: Volatility and Drawdowns

VXUS has been the more volatile fund, with annualized monthly volatility of 15.1% compared with 5.6% for PCRB. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.

The deepest peak-to-trough decline in our data was -7.2% for PCRB and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.

The two funds' monthly returns correlate at 0.67. They move independently enough that combining them can meaningfully diversify a portfolio.

Fees and Cost Over Time

PCRB charges 0.36% per year while VXUS charges 0.05%. On a $10,000 position that is $36 vs $5 annually, a gap of $31 per year that compounds over a long holding period. On income, PCRB currently yields 9.74% against 2.60% for VXUS.

Holdings Overlap

0.0%overlap

PCRB and VXUS share 0 holdings out of 8241 unique holdings combined, representing a 0.0% weight overlap.

Moderate overlap means holding both could provide meaningful diversification benefits.

Frequently Asked Questions

Which is cheaper, PCRB or VXUS?

PCRB has an expense ratio of 0.36% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $31 per year of difference.

Which performed better, PCRB or VXUS?

Over the past year PCRB returned +4.33% vs +27.13% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (3 years), PCRB annualized +3.23% vs +4.66% for VXUS. Past performance does not guarantee future results.

Which is riskier, PCRB or VXUS?

VXUS has been the more volatile fund at 15.1% annualized versus 5.6% for PCRB. Worst drawdown: PCRB -7.2% vs VXUS -39.9%.

Should I hold both PCRB and VXUS?

PCRB and VXUS have a monthly-return correlation of 0.67, so combining them can provide real diversification depending on your allocation goals.

What is the holdings overlap between PCRB and VXUS?

PCRB and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 8241 unique securities.

Which pays a higher dividend, PCRB or VXUS?

PCRB yields 9.74% while VXUS yields 2.60%, so PCRB currently pays the higher dividend yield.

Get Full ETF Analytics

Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.

See inside every ETF you own
$29/moCancel anytime.
Try FundXLS →